The Roche Investor Relations team would like to invite you to the Roche Diagnostics Day that will take place in London on Wednesday, 22 May 2024, starting at 12:00 BST local time and will finish at 15:30 BST with a reception. Please note that the venue has changed, new address mentioned further below.

 

The Roche Diagnostics Day will address the following topics:

  • Mass spectrometry
  • Continuous glucose monitoring
  • Next generation sequencing
  • Point of care
  • Upcoming molecular diagnostics launches
  • Neurology biomarkers in development
 

Presenters include:
Matt Sause, CEO Roche Diagnostics
Alan Hippe, Chief Financial and IT Officer
Palani Kumaresan, Global Head of Roche Diagnostics Solutions (RDS)
Benjamin Lilienfeld, Lifecycle Leader Serum Work Area Systems
Jochen Berchtold, Lifecycle Leader - Continuous monitoring
Ildiko Amann-Zalan, Head of Research & Development Roche Diagnostics Solutions
Nico Michel, Lifecycle Leader Infectious Diseases - Molecular Lab
Jill German, Head of Roche Pathology Customer Area (RDS)
Olivier Gillieron, Lifecycle Leader Cardiometabolic and Neurology

 

Meeting information:
Date/Time (BST):
Wednesday, 22 May 2024
12:00 - 13:00 Registration and lunch
13:00 - 15:30 Presentations & Q&A
15:30 - 16:15 Refreshments with Roche Management Team

 

New Venue
Pan Pacific London
Meeting room: Ballroom
80 Houndsditch
London EC3A 7AB
United Kingdom
> map

 

To register for the event, please follow this > link (passcode: Dia2024).

 

The slides will be available for download at 12:00 BST on the day of the event. > click here

 

Alternatively you may participate virtually in the webinar (no access to speakers, pre-registration required). Please pre-register for the webinar here*.

 

Should you be unable to register for the webinar due to your company IT policy, please send an e-mail to investor.relations@roche.com .

 

A replay of the event will be available via > ir.roche.com
*privacy notice

 

 

Best regards,


 
 
Bruno Eschli
Head of Investor Relations

 
Birgit Masjost
Investor Relations Officer



Roche Investor Relations  
Dr. Bruno Eschli
Phone: +41 61 68-75284
e-mail: bruno.eschli@roche.com

 
Dr. Sabine Borngräber
Phone: +41 61 68-88027
e-mail: sabine.borngraeber@roche.com

 
Dr. Birgit Masjost
Phone: +41 61 68-84814
e-mail: birgit.masjost@roche.com

 
 
 
 
Investor Relations North America  
Loren Kalm
Phone: +1 650 225 3217
e-mail: kalm.loren@gene.com
 

 


get the latest news and updates to your inbox.